Literature DB >> 434227

Morphological and physiological correlation of bradykinin-induced macromolecular efflux.

E Svensjö, K E Arfors, R M Raymond, G J Grega.   

Abstract

Bradykinin applied topically for 4 min produced marked dose-related increases in the number of fluorescent dextran (mol wt 145,000) vascular leakage sites exclusively from small postcapillary venules--evidence for an increase in macromolecular permeability. The increase in macromolecular permeability was short-lived, making repeated applications possible. The number of bradykinin-induced venular fluorescent dextran leakage sites could be greatly reduced by the simultaneous topical application of isoproterenol, and this antagonism of the increase in macromolecular permeability could be prevented by pretreatment with propranolol. The topical application of papaverine failed to antagonize the increase in the number of venular leakage sites of fluorescent dextran by bradykinin. A continuous 90-min superfusion of bradykinin elicited an initial marked increase in the number of fluorescent dextran venular leakage sites, which then waned after 20-30 min, returning to near control despite the continued superfusion with bradykinin. In canine forelimbs the bradykinin-induced increase in protein efflux, total protein transport, and lymph flow also peaked in approximately 30 min and then waned markedly despite continued local intra-arterial infusions of this agent for prolonged periods. The morphological data from the cheek pouch agrees well with the physiological data from the forelimb, suggesting that an increase in protein efflux in the canine forelimb could be readily explained by an increase in the number of large pores.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434227     DOI: 10.1152/ajpheart.1979.236.4.H600

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin.

Authors:  W G Mayhan
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

2.  Evidence that prolonged histamine suffusions produce transient increases in vascular permeability subsequent to the formation of venular macromolecular leakage sites. Proof of the Majno-Palade hypothesis.

Authors:  K L Horan; S W Adamski; W Ayele; J J Langone; G J Grega
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

Review 3.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 4.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

5.  Dose-related antipermeability effect of terbutaline and its inhibition by a selective beta 2-receptor blocking agent.

Authors:  E Svensjö; K Roempke
Journal:  Agents Actions       Date:  1985-03

6.  Passive drug diffusion via standardized skin mini-erosion; methodological aspects and clinical findings with new device.

Authors:  P Svedman; S Lundin; P Höglund; C Hammarlund; C Malmros; N Pantzar
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

7.  Identification of tissue kallikrein messenger RNA in human neutrophils.

Authors:  H F Wu; R D Venezie; W M Cohen; J W Jenzano; G L Featherstone; R L Lundblad
Journal:  Agents Actions       Date:  1993-01

8.  Modulation of arterial endothelial permeability: studies on an in vitro model.

Authors:  J R Gudgeon; W Martin
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

9.  Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Authors:  M G Sirois; W T de Lima; A J de Brum Fernandes; R J Johnson; G E Plante; P Sirois
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Modulation of barrier function of bovine aortic and pulmonary artery endothelial cells: dissociation from cytosolic calcium content.

Authors:  K W Buchan; W Martin
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.